Quantcast
Last updated on April 24, 2014 at 11:55 EDT

Latest Sequenom Inc. Stories

2014-01-12 12:20:22

SAN DIEGO, Jan. 12, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company's 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) -- Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 -- Diagnostic services...

2014-01-09 16:25:35

SAN DIEGO, Jan, 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits provider, to provide coverage for the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives under agreement by Sequenom Laboratories' diagnostic...

2014-01-08 16:26:51

SAN DIEGO, Jan. 8, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced that on January 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing," invented by Drs. Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The Chinese University of Hong Kong. The patent claims novel methods for detecting fetal...

2014-01-06 08:25:15

SAN DIEGO, Jan. 6, 2014 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the J.P. Morgan 32nd Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California on January 13-16, 2014. (Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO) Harry Hixson, Chairman and CEO, William Welch, President and COO, and Paul V....

2013-12-04 08:29:04

SAN DIEGO, Calif. and ST. OUEN L'AUMONE, France, Dec. 4, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced that Laboratoire Cerba has launched its validated noninvasive prenatal test (NIPT) to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa. Laboratoire Cerba's test utilizes patented technology licensed from Sequenom to...

2013-12-03 08:31:51

SAN DIEGO, Dec. 3, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Oppenheimer 24th Annual Healthcare Conference at the Crowne Plaza Hotel in New York, NY on December 10-11, 2013. William Welch, President and COO, Paul V. Maier, Chief Financial Officer and Ronald M. Lindsay, Ph.D., EVP Strategic Planning, will present on Tuesday,...

2013-11-21 08:26:54

SAN DIEGO, Nov. 21, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Piper Jaffray 25th Annual Health Care Conference at the New York Palace Hotel in New York, NY on December 3-4, 2013. William Welch, President and COO, Paul V. Maier, Chief Financial Officer and Ronald M. Lindsay, Ph.D., EVP Strategic Planning, will present on...

2013-11-07 16:31:43

Announces Record Revenue for the Quarter SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $44.0 million for the third quarter of 2013, an increase of 26% compared to revenues of $34.9 million for the second quarter of 2013, and an increase of 92% compared to revenues of $22.9 million for the third quarter of 2012. "We are proud to report...

2013-10-31 12:26:51

SAN JOSE, Calif., Oct. 31, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., won summary judgment yesterday in a patent infringement litigation involving U.S. Patent No. 6,258,540 against Sequenom, Inc., an exclusive licensee of the patent from Isis Innovations, Inc. The United States District Court for the Northern District of California invalidated the '540 patent at issue, giving Ariosa a complete victory in the case. The patent at issue is related to the detection of fetal cell-free...

2013-10-24 08:33:35

SAN DIEGO, Oct. 24, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the third quarter of 2013 after closing of the NASDAQ Global Market on Thursday, November 7, 2013. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EST (2:00...